Inflammatory Bowel Diseases




دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
    http://medilib.ir
  • ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
  • قیمت : 3,800,000 تومان
  • قیمت ویژه : 1,900,000تومان
سفارش

Comparative Efficacy of Infliximab vs Ustekinumab for Maintenance of Clinical Response in Biologic Naïve Crohn’s Disease

Emily C L Wong, BHSc, Parambir S Dulai, MD, John K Marshall, MD, MSc, Vipul Jairath, MD, PhD, Walter Reinisch, MD, PhD, Neeraj Narula, MD, MPH

doi : 10.1093/ibd/izac168

Inflammatory Bowel Diseases, Volume 29, Issue 7, July 2023, Pages 1015–1023

There is a need to better understand the positioning of biologic therapies for long-term outcomes in biologic-naïve Crohn’s disease (CD). We assessed the comparative effectiveness of infliximab and ustekinumab among induction responders for 1-year outcomes.

خرید پکیج و مشاهده آنلاین مقاله


Serum Lipidomic Screen Identifies Key Metabolites, Pathways, and Disease Classifiers in Crohn’s Disease

Romain Ferru-Clément, PhD, Gabrielle Boucher, MSc, Anik Forest, MSc, Bertrand Bouchard, MSc, Alain Bitton, MD, Sylvie Lesage, PhD, Phil Schumm, PhD, Mark Lazarev, MD, Steve Brant, MD, Richard H Duerr, MD, Dermot P B McGovern, MD PhD, Mark Silverberg, MD PhD, Judy H Cho, MD, NIDDK IBD Genetics Consortium, iGenoMed Consortium, Ashwin Ananthakrishnan, MD, Ramnik J Xavier, MD, John D Rioux, PhD, Christine Des Rosiers, PhD

doi : 10.1093/ibd/izac281

Inflammatory Bowel Diseases, Volume 29, Issue 7, July 2023, Pages 1024–1037,

There is an unmet medical need for biomarkers that capture host and environmental contributions in inflammatory bowel diseases (IBDs). This study aimed at testing the potential of circulating lipids as disease classifiers given their major roles in inflammation.

خرید پکیج و مشاهده آنلاین مقاله


Ustekinumab Tissue and Serum Levels in Patients With Crohn’s Disease Are Closely Correlated Though Not Consistently Associated With Objective Response After Induction

Elisa Proietti, PhD, Renske W M Pauwels, MD, PhD, Christien J van der Woude, MD, PhD, Michael Doukas, MD, PhD, Lindsey Oudijk, MD, PhD, Maikel P Peppelenbosch, PhD, Ursula Grohmann, PhD, Marie-Rose B S Crombag, PharmD, PhD, Annemarie C de Vries, MD, PhD, Gwenny M Fuhler, PhD

doi : 10.1093/ibd/izac169

Inflammatory Bowel Diseases, Volume 29, Issue 7, July 2023, Pages 1038–1046

Ustekinumab (UST), which targets p40/interleukin (IL)-23 and IL-12, is an effective treatment for Crohn’s disease (CD). Therapeutic drug monitoring may optimize UST posology. The aim of this study was to investigate UST and IL-23 serum and tissue concentrations in relation to mucosal inflammation and treatment response at an early time point.

خرید پکیج و مشاهده آنلاین مقاله


Risks of Melanoma and Nonmelanoma Skin Cancers Pre– and Post–Inflammatory Bowel Disease Diagnosis

Mariam Narous, MD, Zoann Nugent, PhD, Harminder Singh, MD, Charles N Bernstein, MD

doi : 10.1093/ibd/izac171

Inflammatory Bowel Diseases, Volume 29, Issue 7, July 2023, Pages 1047–1056

We compared risks of nonmelanoma skin cancers (NMSCs) and melanoma preceding and following a diagnosis of inflammatory bowel disease (IBD) and to evaluate the effect of thiopurines and anti-tumor necrosis factor α (anti-TNF-α) on skin cancer risk in IBD.

خرید پکیج و مشاهده آنلاین مقاله


Occurrence and Clinical Impact of Eosinophilic Esophagitis in a Large Cohort of Children With Inflammatory Bowel Disease

Marina Aloi, MD, PhD, Giulia D’Arcangelo, MD, Danilo Rossetti, MD, Simone Bucherini, MD, Enrico Felici, MD, Claudio Romano, MD, Massimo Martinelli, MD, Valeria Dipasquale, MD, Paolo Lionetti, MD, Salvatore Oliva, MD, PhD

doi : 10.1093/ibd/izac172

Inflammatory Bowel Diseases, Volume 29, Issue 7, July 2023, Pages 1057–1064

Scarce data have investigated the association between pediatric inflammatory bowel disease (IBD) and eosinophilic esophagitis (EoE). We, therefore, aimed to describe the epidemiology and the possible peculiar phenotype and natural history of such an association.

خرید پکیج و مشاهده آنلاین مقاله


Young Adult Male Patients With Childhood-onset IBD Have Increased Risks of Compromised Cortical and Trabecular Bone Microstructures

Gudmundur Vignir Sigurdsson, MD, Susanne Schmidt, MD, PhD, Dan Mellström, MD, Claes Ohlsson, MD, Robert Saalman, MD, Mattias Lorentzon, MD

doi : 10.1093/ibd/izac181

Inflammatory Bowel Diseases, Volume 29, Issue 7, July 2023, Pages 1065–1072

Young adults with childhood-onset inflammatory bowel disease (IBD) have increased risks of low areal bone mineral density and low skeletal muscle mass. Volumetric BMD (vBMD), bone geometry and microstructures, in addition to possible associations with skeletal muscle index (SMI) and physical exercise have been scarcely studied in this patient group.

خرید پکیج و مشاهده آنلاین مقاله


Aeroallergen-related Diseases Predate the Diagnosis of Inflammatory Bowel Disease

Namarik Alenezy, MD, Zoann Nugent, PhD, Sari Herman, MD, Karver Zaborniak, MD, Clare D Ramsey, MD, Charles N Bernstein, MD

doi : 10.1093/ibd/izac184

Inflammatory Bowel Diseases, Volume 29, Issue 7, July 2023, Pages 1073–1079

This study aimed to determine whether having a diagnosis of asthma or allergic rhinitis (AR) increased the risk of being diagnosed with inflammatory bowel disease (IBD) and whether there was increased incidence of these diseases after a diagnosis of IBD.

خرید پکیج و مشاهده آنلاین مقاله


Infliximab Trough Levels Are Associated With Transmural Sonographic Healing in Inflammatory Bowel Disease

Rose Vaughan, MBBS, Elise Murphy, MClinPharm, Michelle Nalder, MClinPharm, Robert N Gibson, MD, Zaid Ardalan, MBChB, Alex Boussioutas, PhD, Britt Christensen, PhD

doi : 10.1093/ibd/izac186

Inflammatory Bowel Diseases, Volume 29, Issue 7, July 2023, Pages 1080–1088

Mucosal healing improves clinical outcomes in patients with inflammatory bowel disease (IBD) and is associated with higher infliximab trough levels (ITLs). Transmural healing, assessed by intestinal ultrasound (IUS), is emerging as an objective target in Crohn’s disease (CD) and ulcerative colitis (UC). This study explores the correlation between maintenance ITLs and sonographic transmural healing.

خرید پکیج و مشاهده آنلاین مقاله


Validating the Simplified Endoscopic Mucosal Assessment for Crohn’s Disease: A Novel Method for Assessing Disease Activity

Jeremy Adler, MD, MSc, Richard B Colletti, MD, Lenore Noonan, RT, Tyler M Berzin, MD, Adam S Cheifetz, MD, Laurie S Conklin, MD, Timothy C Hoops, MD, Christopher S Huang, MD, Blair Lewis, MD, Daniel S Mishkin, MD, Kim Hung Lo, PhD, Yongling Xiao, PhD, Sheri Volger, PhD, RDN

doi : 10.1093/ibd/izac183

Inflammatory Bowel Diseases, Volume 29, Issue 7, July 2023, Pages 1089–1097

To demonstrate treatment efficacy in Crohn’s disease (CD), regulatory authorities require that trials include an endoscopic remission/response end point; however, standardized endoscopic assessment of disease activity, such as the Simple Endoscopic Score for Crohn’s Disease (SES-CD), is not typically recorded by clinicians in practice or outside of clinical trials.

خرید پکیج و مشاهده آنلاین مقاله


Peripartum Infections Among Women With Inflammatory Bowel Disease

Bar Narkis, MD, Eran Hadar, MD, Shiri Barbash-Hazan, MD, Ohad Houri, MD, Vardit Shay, M.Sc, Jacob E Ollech, MD, Henit Yanai, MD, Iris Dotan, MD, Irit Avni-Biron, MD

doi : 10.1093/ibd/izac185

Inflammatory Bowel Diseases, Volume 29, Issue 7, July 2023, Pages 1098–1104

Pregnant patients with inflammatory bowel diseases (IBDs) are frequently treated with immunomodulatory agents and may be at increased risk of adverse outcomes, including peripartum infections. We sought to examine the risk for peripartum infections in patients with IBD compared with control subjects and identify potential risk factors associated with peripartum infections in these patients.

خرید پکیج و مشاهده آنلاین مقاله


A Novel Probiotic Combination Ameliorates Crohn’s Disease–Like Ileitis by Increasing Short-Chain Fatty Acid Production and Modulating Essential Adaptive Immune Pathways

Luca Di Martino, PhD, Abdullah Osme, MD, Mahmoud Ghannoum, PhD, Fabio Cominelli, MD, PhD

doi : 10.1093/ibd/izac284

Inflammatory Bowel Diseases, Volume 29, Issue 7, July 2023, Pages 1105–1117,

Crohn’s disease (CD) represents a significant public health challenge. We identified a combination of beneficial probiotic strains (Saccharomyces boulardii, Lactobacillus rhamnosus, Lactobacillus acidophilus, and Bifidobacterium breve) and amylase that may antagonize elevated bacterial pathogens in the inflamed gut.

خرید پکیج و مشاهده آنلاین مقاله


Microbial Dynamics in Newly Diagnosed and Treatment Naïve IBD Patients in the Mediterranean

Philipp Rausch, PhD, Sarah Ellul, MD, Anthea Pisani, MD, Corinna Bang, PhD, Trevor Tabone, MD, Claire Marantidis Cordina, MD, Graziella Zahra, MD, Andre Franke, PhD, Pierre Ellul, MD

doi : 10.1093/ibd/izad004

Inflammatory Bowel Diseases, Volume 29, Issue 7, July 2023, Pages 1118–1132,

Microbial communities have long been suspected to influence inflammatory processes in the gastrointestinal tract of patients with inflammatory bowel disease. However, these effects are often influenced by treatments and can rarely be analyzed in treatment-naïve onset cases.

خرید پکیج و مشاهده آنلاین مقاله


Inhibition of Soluble Stem Cell Factor Promotes Intestinal Mucosal Repair

Vicky Garcia-Hernandez, PhD, Arturo Raya-Sandino, PhD, Veronica Azcutia, PhD, Jael Miranda, PhD, Matthias Kelm, MD, Sven Flemming, MD, Dorothee Birkl, MD, Miguel Quiros, PhD, Jennifer C Brazil, PhD, Charles A Parkos, MD, PhD, Asma Nusrat, MD

doi : 10.1093/ibd/izad003

Inflammatory Bowel Diseases, Volume 29, Issue 7, July 2023, Pages 1133–1144

Incidences of inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, are escalating worldwide and can be considered a global public health problem. Given that the gold standard approach to IBD therapeutics focuses on reducing the severity of symptoms, there is an urgent unmet need to develop alternative therapies that halt not only inflammatory processes but also promote mucosal repair.

خرید پکیج و مشاهده آنلاین مقاله


Endoscopic Stenting in Crohn’s Disease-related Strictures: A Systematic Review and Meta-analysis of Outcomes

Saurabh Chandan, MD, Banreet S Dhindsa, MD, Shahab R Khan, MBBS, Smit Deliwala, MD, Lena L Kassab, MD, Babu P Mohan, MD, Ojasvini C Chandan, MD, Carme Loras, MD, PhD, Bo Shen, MD, Gursimran S Kochhar, MD

doi : 10.1093/ibd/izac153

Inflammatory Bowel Diseases, Volume 29, Issue 7, July 2023, Pages 1145–1152

Crohn’s disease (CD) is a chronic progressive condition that is complicated by intestinal or colonic stricture in nearly 30% of cases within 10 years of the initial diagnosis.

خرید پکیج و مشاهده آنلاین مقاله


The Oral-Gut Axis: Periodontal Diseases and Gastrointestinal Disorders

Gretchen A Lam, DMD, Hala Albarrak, BDS, Cassidy J McColl, MSc, Alaina Pizarro, Harsha Sanaka, Adrian Gomez-Nguyen, PhD, Fabio Cominelli, MD, PhD, Andre Paes Batista da Silva, DDS, Msc, PhD

doi : 10.1093/ibd/izac241

Inflammatory Bowel Diseases, Volume 29, Issue 7, July 2023, Pages 1153–1164

One of the prospective sequelae of periodontal disease (PD), chronic inflammation of the oral mucosa, is the development of inflammatory gastrointestinal (GI) disorders due to the amplification and expansion of the oral pathobionts.

خرید پکیج و مشاهده آنلاین مقاله


Impact of Biologic Agents on the Immune Response Induced by the Additional Dose of SARS-CoV-2 Vaccine in Inflammatory Bowel Disease Patients

Laura Ramos, MD, Miriam Hernández-Porto, PhD, Marta Carrillo-Palau, MD, PhD, Inmaculada Alonso-Abreu, MD, PhD, Cristina Reygosa, MD, Manuel Hernandez-Guerra, MD, PhD

doi : 10.1093/ibd/izac228

Inflammatory Bowel Diseases, Volume 29, Issue 7, July 2023, Pages 1165–1169

خرید پکیج و مشاهده آنلاین مقاله


The Modified Mucosal Inflammation Noninvasive Index and Endoscopic Remission in Adults With Crohn’s Disease

Dotan Yogev, MD, Bram Verstockt, MD, PhD, Axel Dignass, MD, PhD, Gili Focht, MSc, MBA, Ohad Atia, MD, Iris Dotan, MD, PhD, Severine Vermeire, MD, PhD, Dan Turner, MD, PhD

doi : 10.1093/ibd/izac235

Inflammatory Bowel Diseases, Volume 29, Issue 7, July 2023, Pages 1170–1174

خرید پکیج و مشاهده آنلاین مقاله


Rapid Clinical Remission With Upadacitinib in a Pediatric Patient With Refractory Crohn’s Disease

Lauren V Collen, MD

doi : 10.1093/ibd/izad048

Inflammatory Bowel Diseases, Volume 29, Issue 7, July 2023, Pages 1175–1176

خرید پکیج و مشاهده آنلاین مقاله


Frail Phenotype in Patients With Inflammatory Bowel Disease

Cong Dai, MD, PhD, Yu-Hong Huang, MD

doi : 10.1093/ibd/izac278

Inflammatory Bowel Diseases, Volume 29, Issue 7, July 2023, Page e30

خرید پکیج و مشاهده آنلاین مقاله


آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟